Dr. Sven Mensing is currently the Head of Pharmacometrics at AbbVie, where they lead a team of 30 quantitative scientists to provide data-driven assessments that optimize clinical development strategies. They hold a PhD in Medical Informatics from the University of Heidelberg and a B.S. and M.S. in Biomathematics from the University of Greifswald. Dr. Mensing began their career at Abbott in 2004 and transitioned to AbbVie in 2008, where they have contributed significantly to pharmacometric analyses in drug development. They are also an inventor on several patents related to HCV treatment and have published numerous manuscripts in international scientific meetings.
This person is not in any teams
This person is not in any offices